Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
06/2009
06/11/2009US20090149445 Tricyclic steroid hormone nuclear receptor modulators
06/11/2009US20090149444 Benzylamine analogues
06/11/2009US20090149425 Malononitrile compound as pesticides
06/11/2009US20090149356 Environmentally friendly bis-quaternary compounds for inhibiting corrosion and removing hydrocarbonaceous deposits in oil and gas applications
06/11/2009US20090148382 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
06/11/2009US20090145757 Redox Polymers
06/11/2009CA2706340A1 Process for the preparation of 5-(2-ethyl-dihydro-1h-inden-2-yl)-1h-imidazole and salts thereof
06/10/2009EP2067774A1 Perchloric acid ion trapping agent
06/10/2009EP2066672A1 An improved process for the preparation of temozolomide and analogs
06/10/2009EP2066642A1 Soluble epoxide hydrolase inhibitors
06/10/2009EP2066632A1 Benzophenone derivatives useful for inhibiting formation of microtubule
06/10/2009EP2066619A2 Soluble epoxide hydrolase inhibitors
06/10/2009EP0854870B1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity
06/10/2009CN101450930A Synthesis and purification method of hydrochloride-1-amido glycolyurea
06/10/2009CN101450929A Method for removing salt from hydrochloride-1-amido glycolyurea
06/10/2009CN100497358C Iridium compound and organic electroluminescent device using the same
06/10/2009CN100497336C Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof
06/09/2009US7544813 Ionic liquids
06/09/2009US7544812 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus
06/09/2009US7544808 9-[4-[4-[[2-(2,2,2-trifluoroethoxy)benzoyl]amino]-1-piperidinyl]butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide; non-steroidal modulator of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity, obesity, diabetes, inflammatory and immune diseases
06/09/2009US7544807 Ionic liquids
06/09/2009US7544800 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents
06/09/2009CA2355720C New substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
06/04/2009WO2009070045A2 Imidazole derivatives, process for their preparation, and thier pharmaceutical use
06/04/2009WO2009016514A3 1, 3 and 1, 3, 5 substituted imidazoles as antihypertensiva
06/04/2009WO2008098674A3 Phenoxymethyl imidazoline derivatives and their use as pesticides
06/04/2009WO2007129184A3 An improved process for the preparation of phenytoin sodium
06/04/2009WO2001060458A3 Inhibitors of prenyl-protein transferase
06/04/2009US20090143597 Ionic Liquids Based on Imidazolium Salts Incorporating a Nitrile Functionality
06/04/2009US20090143591 Scalable synthesis of imidazole derivatives
06/04/2009US20090143452 Use of prochloraz for wood protection
06/04/2009US20090143435 GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity
06/04/2009US20090143386 Human adam-10 inhibitors
06/04/2009US20090143370 Non-nucleoside Reverse Transcriptase Inhibitors
06/04/2009US20090143364 Chiral cis-imidazolines
06/03/2009EP2065471A1 Method for producing basic amino acid
06/03/2009EP2064951A1 Use of a substituted imidazole, derivatives or salts thereof for the preparation of a medicament for the treatment of a cell proliferative disorder
06/03/2009EP2064202A2 A new crystalline form g of (5s)-5-[4-(5-chloro-pyridin-2-yloxy)-piperidine-1-sulfonyl-methyl]-5-methyl-imidazolidine-2,4-dione (i) and intermediates thereof.
06/03/2009EP2064177A2 Protease inhibitors
06/03/2009EP1910310B1 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
06/03/2009CN101448793A Urea type cinnamide derivative
06/03/2009CN100494203C Functionalized ionic liquids, and methods of use thereof
06/03/2009CN100494182C Regulatory factor of tumor necrosis alpha factor
06/02/2009US7541476 Radiolabeled astemizole and method of making
06/02/2009US7541383 Use of carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer; treatment of asthma, allergic diseases and immunologic diseases
06/02/2009US7541375 Azole derivatives and pharmaceutical compositions containing them
06/02/2009US7541374 Malononitrile compounds and use thereof
06/02/2009CA2319138C Method for producing s-alkyl(aryl)-substituted imidazol derivatives
05/2009
05/28/2009WO2009067600A2 Biaryl pde4 inhibitors for treating inflammation
05/28/2009WO2009027250A3 Distillation of ionic liquids
05/28/2009US20090137817 Spatially-defined macrocyclic compounds useful for drug discovery
05/28/2009US20090137815 Process for Making Cytokine Inhibiting Compounds Containing 4- and 5-Imidazolyl Rings and the Intermediates Thereof
05/28/2009US20090137808 Process for manufacturing bisphosphonic acids
05/28/2009US20090137653 Substituted benzylamines as cyp2a inhibitors and uses thereof to treat nicotine dependence
05/28/2009US20090137591 Compounds and compositions as ppar modulators
05/28/2009US20090137175 Sizing Composition For Glass Fibers, Sized Glass Fibers, And Reinforced Products Comprising The Same
05/28/2009CA2722582A1 Biaryl pde4 inhibitors for treating inflammation
05/27/2009EP2061768A2 Imidazole-4,5-dicarboxamide derivatives as jak-2 modulators
05/27/2009EP2061767A1 Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
05/27/2009EP2061760A1 Benzo-fused compounds for use in treating metabolic disorders
05/27/2009EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators
05/27/2009EP1222174B1 Imidazol-4-ylmethanols used as inhibitors of steroid c17-20 lyase
05/27/2009EP1095275B1 Endogenous constitutively activated g protein-coupled orphan receptors
05/27/2009EP0934287B1 Heterocyclic esters and amides
05/27/2009CN101443482A Porous metal organic framework based on pyrroles and pyridinones
05/27/2009CN100491356C Compounds exhibiting thrombopoietin receptor agaonism
05/27/2009CN100491355C Cyclic diamine compound having five-membered cyclic group
05/26/2009US7538228 Transition metal complexes of ligands, e.g., oxzolines, bis-oxazolines, phosphine oxazolines and analgous thiazolines, imidazolines, pyrazolines; conformational rigidity for high enantioselectivity using bidentate ligands; catalyzed reactions include hydrogenation, hydrosilation, hydroboration and others
05/26/2009US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4
05/26/2009US7538125 Pioglitazone insulin sensitivity enhancer with the antidiabetic glimepiride; difference in mechanism of action avoids adverse reactions over long term use; oral dosage tablet; lactose excipient, hydroxypropylcellulose binder, magnesium stearate lubricant, calcium carbonate disintegrator; diabetes
05/26/2009CA2393821C Substituted imidazole neuropeptide y y5 receptor antagonists
05/26/2009CA2254420C Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
05/26/2009CA2225903C Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
05/26/2009CA2216653C 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity
05/22/2009WO2008142576A3 1,(3,)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation
05/22/2009WO2008102359A9 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
05/22/2009WO2008055852A8 Method for preparing medetomidine and its salts
05/22/2009WO2008043567A8 2-phenyl indene derivatives useful as estrogen receptor ligands
05/21/2009US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease
05/20/2009EP1773348A4 Tetrapeptide analogs
05/20/2009EP1534686B1 Nf-kb inhibitors and uses thereof
05/20/2009DE60226032T2 Neue imidazolidinderivate, deren herstellung und verwendung als vla4-antagonisten New imidazolidine derivatives, their preparation and use as VLA4 antagonists
05/20/2009CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments
05/19/2009US7534893 Imidazol-2-one compounds useful in the treatment of various disorders
05/19/2009US7534814 Mutilin derivatives and their use as antibacterials
05/19/2009US7534805 Imidazole derivatives, their preparation and their use as medicaments
05/19/2009CA2468879C Substituted cyclohexane derivatives
05/19/2009CA2309856C Process for the production of formylimidazoles
05/14/2009WO2009061744A2 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
05/14/2009WO2009060742A1 Organic electroluminescent device, display device, and illuminating device
05/14/2009WO2009060215A1 Polyamides
05/14/2009WO2009060174A1 Haloalkylsubstituted aryloxyalkylimidazolines for use as pesticides
05/14/2009WO2009060173A1 Nitrosubstituted aryloxyalkylimidazolines for use as pesticides
05/14/2009WO2009059934A1 Method for producing ionic liquids by anion exchange
05/14/2009US20090124681 Beta-lactone compounds
05/14/2009US20090124674 Method for treating congestive heart failure
05/14/2009US20090124673 Method for treating diabetic nephropathy
05/14/2009US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors
05/14/2009DE102007053630A1 Verfahren und Herstellung ionischer Flüssigkeiten durch Anionenaustausch Procedures and preparation of ionic liquids by anion exchange
05/14/2009DE102007052900A1 Stereospezifische Hydroxylierung Stereospecific hydroxylation
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 345